Glycolytic Reprogramming | List of Frontiers open access articles

Review

Published on 07 Oct 2025

Glycolytic reprogramming during microglial polarization in neurological diseases

in Multiple Sclerosis and Neuroimmunology

Xiaoting Li
Congcong Fang
Yina Li
Xiaoxing Xiong
Xu Xu
Lijuan Gu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1648887

6,339 views
8 citations

Original Research

Published on 22 Aug 2023

Glycolytic reprogramming in macrophages and MSCs during inflammation

in Molecular Innate Immunity

Xueping Li
Huaishuang Shen
Mao Zhang
Victoria Teissier
Ejun Elijah Huang
Qi Gao
Masanori Tsubosaka
Masakazu Toya
Junichi Kushioka
Chima V. Maduka

Frontiers in Immunology

doi 10.3389/fimmu.2023.1199751

24,491 views
61 citations

Brief Research Report

Published on 06 Jan 2026

Glycolytic reprogramming of resident alveolar macrophages contributes to reduced SOCS3 secretion in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Jennifer M. Speth
Mikel D. Haggadone
Marc Peters-Golden

Frontiers in Immunology

doi 10.3389/fimmu.2025.1708467

1,347 views

Original Research

Published on 27 Nov 2025

DANCR promotes septic cardiomyopathy by enhancing macrophage glycolytic reprogramming via the IGF2BP2/HK2 axis

in Epigenomics and Epigenetics

Chunhui Ma
Shaoyu Liu
Yu Zhao
Hong Liu
Xuguang Zhang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2025.1628915

1,518 views

Review

Published on 10 Apr 2026

Glycolytic reprogramming and immune responses in macrophages: a crosstalk driven by bacterial infection

in Microbial Immunology

Wei-ren Wang
Lin Yan
Chuan-ying Zhao
Cong-cong He
Xing-Hua Gao

Frontiers in Immunology

doi 10.3389/fimmu.2026.1783266

671 views

Review

Published on 25 Jul 2024

Revisiting the role of hypoxia-inducible factors and nuclear factor erythroid 2-related factor 2 in regulating macrophage inflammation and metabolism

in Adaptive & Innate Immunity in Infection

Kenneth K. Y. Ting

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1403915

4,476 views
14 citations

Original Research

Published on 10 Apr 2026

Immunometabolic reprogramming of Mycobacterium tuberculosis-responsive memory CD4+ T cell subsets is linked to long-term protective immunity

in Immunological Basis of Tuberculosis

Vaishnavi Kaipilyawar
Samantha Leong
Arianne Lovey
Lorenzzo L. Stringari
Reynaldo Dietze
Jerrold J. Ellner
Rodrigo Ribeiro-Rodrigues
Padmini Salgame

Frontiers in Tuberculosis

doi 10.3389/ftubr.2026.1783887

490 views

Review

Published on 30 Mar 2026

Immunometabolic dysregulation in autoimmune rheumatic diseases: the central role of glycolytic reprogramming in pathogenesis and traditional Chinese medicine therapy

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Jianting Wen
Jian Liu
Lei Wan
Fanfan Wang
Yang Li

Frontiers in Immunology

doi 10.3389/fimmu.2026.1754832

617 views

Original Research

Published on 25 Aug 2022

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

in T Cell Biology

Preston R. Arnold
Mou Wen
Lei Zhang
Yuanlin Ying
Xiang Xiao
Xiufeng Chu
Guangchuan Wang
Xiaolong Zhang
Zhuyun Mao
Aijun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2022.966364

7,266 views
18 citations

Review

Published on 21 Apr 2026

Glucose metabolic reprogramming: a novel strategy to enhance radiotherapy response to triple-negative breast cancer

in Radiation and Health

Lu Gan
Qian Li
Boyi Yu
Jing Si
Qiang Li
Weiqiang Chen
Bing Wang

Frontiers in Public Health

doi 10.3389/fpubh.2026.1715716

584 views

Original Research

Published on 18 Jul 2022

Inhibition of Glycolysis Impairs Retinoic Acid-Inducible Gene I–Mediated Antiviral Responses in Primary Human Dendritic Cells

in Virus and Host

Alessandra Zevini
Enrico Palermo
Daniele Di Carlo
Magdalini Alexandridi
Serena Rinaldo
Alessio Paone
Francesca Cutruzzola
Marilena P. Etna
Eliana M. Coccia
David Olagnier

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.910864

5,566 views
13 citations

Original Research

Published on 16 Sep 2021

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

in Respiratory Pharmacology

Weimou Chen
Jinming Zhang
Wenshan Zhong
Yuanyuan Liu
Ye Lu
Zhaojin Zeng
Haohua Huang
Xuan Wan
Xiaojing Meng
Fei Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2021.744826

11,802 views
52 citations

Review

Published on 04 Sep 2025

Harnessing glycolysis in gastric cancer: molecular targets, therapeutic strategies, and clinical horizons

in Cancer Immunity and Immunotherapy

Zexing Shan
Yefu Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1628937

6,177 views
5 citations

Systematic Review

Published on 14 Jan 2025

Research progresses and hotspots on glucose metabolic reprogramming in breast cancer: a bibliometric analysis over the past two decades

in Cancer Metabolism

Lei Huang
Wenyue Zhao
Lamei Sun
Dong Niu
Xiaodan Zhu
Chunhui Jin

Frontiers in Oncology

doi 10.3389/fonc.2024.1493996

2,911 views
1 citation

Original Research

Published on 10 Dec 2021

Hematopoietic Cell-Specific SLC37A2 Deficiency Accelerates Atherosclerosis in LDL Receptor-Deficient Mice

in Lipids in Cardiovascular Disease

Qingxia Zhao
Zhan Wang
Allison K. Meyers
Jennifer Madenspacher
Manal Zabalawi
Qianyi Zhang
Elena Boudyguina
Fang-Chi Hsu
Charles E. McCall
Cristina M. Furdui

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.777098

5,580 views
5 citations

Original Research

Published on 08 Apr 2019

FcγR-TLR Cross-Talk Enhances TNF Production by Human Monocyte-Derived DCs via IRF5-Dependent Gene Transcription and Glycolytic Reprogramming

in Antigen Presenting Cell Biology

Willianne Hoepel
Melissa Newling
Lisa T. C. Vogelpoel
Lathees Sritharan
Ivo S. Hansen
Martien L. Kapsenberg
Dominique L. P. Baeten
Bart Everts
Jeroen den Dunnen

Frontiers in Immunology

doi 10.3389/fimmu.2019.00739

9,851 views
37 citations

Articles

Glycolytic reprogramming during microglial polarization in neurological diseases

Glycolytic reprogramming in macrophages and MSCs during inflammation

Glycolytic reprogramming of resident alveolar macrophages contributes to reduced SOCS3 secretion in non-small cell lung cancer

DANCR promotes septic cardiomyopathy by enhancing macrophage glycolytic reprogramming via the IGF2BP2/HK2 axis

Glycolytic reprogramming and immune responses in macrophages: a crosstalk driven by bacterial infection

Revisiting the role of hypoxia-inducible factors and nuclear factor erythroid 2-related factor 2 in regulating macrophage inflammation and metabolism

Immunometabolic reprogramming of Mycobacterium tuberculosis-responsive memory CD4+ T cell subsets is linked to long-term protective immunity

Immunometabolic dysregulation in autoimmune rheumatic diseases: the central role of glycolytic reprogramming in pathogenesis and traditional Chinese medicine therapy

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

Glucose metabolic reprogramming: a novel strategy to enhance radiotherapy response to triple-negative breast cancer

Inhibition of Glycolysis Impairs Retinoic Acid-Inducible Gene I–Mediated Antiviral Responses in Primary Human Dendritic Cells

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

Harnessing glycolysis in gastric cancer: molecular targets, therapeutic strategies, and clinical horizons

Research progresses and hotspots on glucose metabolic reprogramming in breast cancer: a bibliometric analysis over the past two decades

Hematopoietic Cell-Specific SLC37A2 Deficiency Accelerates Atherosclerosis in LDL Receptor-Deficient Mice

FcγR-TLR Cross-Talk Enhances TNF Production by Human Monocyte-Derived DCs via IRF5-Dependent Gene Transcription and Glycolytic Reprogramming